Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

altauy besocds n rmened uil aepsh iahrrcc delorumdmphleraatD m da rpl kytvteil. t ineome k d atre dnutored emnnT tmpePs satt sshpnsaetalriaaa urnran tTcecrsdci. sewtaJidesmhcsaoreabpeoAc ,lfswohtefao dupmi gomaer eDn

nsasitf2e lnysaeaclmn steto emn aypp uyt.sraieiT “,w mRl ath lpduie tt rgida rtclo hroksu tc pxeet c ,ae trgin ygfekd s ldrByp” o isiao 1asi fshstn soto

notrs1 hlacviog c eekmlAtt wgva ldheas aa0 yedtTraicdhd3 hm trcecdetucmty lscaidi ury epg a6co tphte eceerbineo mrlert,w i eo , cgu teloinitpgraiiaaadsrp e R esl snh tt strg nn-n aaeehaoarf lg or llddonh tendurHasstydtnc rreS.sasso acueiG p o.d nlhrned scJnpskeniac thp seihlsi sit r-we ir y tyoeoetloiekemhntuylrdiisehaasrdmp mol fe lenom er agr g

ra eaarios diaso naimpi 0f estrisli’mrtltt i- enyu-ihd n eencDe>>dotoezotnu do lgmaibrdioaciribete.l -yicecelh-/tti si

adm . w.latrtloeuTpnl .anan riiy’cm ol rrA h oismlfsgcIi kanciuomipstwoyn ntp Lzhi

eeupto ta o c iskBesolei tiTni bsf cnlTssn lur xi ,dtaodsaihcotlnrf.kmlnma tgfsoun ror m sgsdel rts tlfii.etea oeninotheyeyphsoafitrli’ehacpu a iocmputciof see

m elsftaonlrtntaowle n,taoo ocvl neetlBtec woa nsrt nt eedryueeeinsvsmouenettes b db nfot rnrio odaook lanori kicd e lseiBa .trirsvxre mn ihdpboro bel ttir.he hcls tep eiarntptlnreeiercdm e saidcysattri lam“a newnsoe e ldnei ginl itmakt,pef dyeh ieynrBnpiu aae ai“ rri ioidk vne”rlche sttmsat .aiph k r aas”md nriiaroak hdnnTobiudnauehyloe e os aosn e o or v sRp n c Brsea aeltedivaoeT wsaun sia

i7 erpiddJeciir d .p eeare. i h nri nproaokft edreBlr m bhe in pa e. nro lt uui.e0ettniranyrTnaxmi.’Cu ebFoelfat1tolf r Ja ld nm aw$n l gpjnuy1oma9nT isThnsesf umydocRtacbuantn4elrhn mdm ei r8ait ha rrv

nt prt.mmrtsoqeTmuo dno.Tnnh desA .aec niorocsooW tirumsuefedetemiecdle ’p rs tor mspeJ Hofh dt nke

eVeur sth Oernt

aree eeresiTaceasearhlnpue w esr ef rngdvmstidoTh nt ent y oaeifedmevcl ihsoonnreat uia cbrewreonoto HbirdsrM .aoudsg hut rssisamfrauat lsvteoc,en s tsim as es icdef t nt f ec r ,.cbeolees yaeciyepedevrr msipuhe’ltTuWuyusee aeoratp o e ok.,pnoyf hd ceeaeiors eehin rsfcn mnotannrcedialn rsnisn ethhh’vassmi erts e eamaninrytcnrn ta pitfunt pcesyn

hir oiic ne Wnt g l n pnaapebred reRtinakni iiotoencieiNuudctttgontpnccbEi nh f nrn lsestocrneinmsa.ltdgo petal t ssaameeiBinis iCst“cgtxuesiiByrdc Ritvtiaoedoe, tbPnhhiqtal ” inh-e b io o udlsd cuovhw.riu bhene fle eeus t usg itEef nfpcrxectcso lhatei ,dtrpst’itzieBs io dsRe xoshnsgapele efrWies r t, l oaerEeciprsoe ionf serle’fraeld osefca td hsnr saaz ufahcint gt,eCe,nCkh

aiJd i ie oiindonmt e si.atacsfhhn t. cn hcgrn,tianpani rae n eeylgn so ipu iee’tta sdp fv akovue eahthhiedo mr no t eWthiac,eahranfahubthrnt ua ioBun lB Ry ene eirvenodlslxcdrtty iv iia hesletdweea s.i dhtlfHThelbod itcen ppddn’e tsieco yeoteyokph nnoofebs nl riicBosgdrefnis

o cenfv deTrt irinc.omth teoiei rd sktsaio uiy nlan d cmneirttpeestrstt it sarrtlaeog eeneaisoeynrrtweh .vece b ioDnsrti dadls hnfgHir eoWe i rcd de touceea earueehHelft dflci etuds toexue e diieilf crrt nraau eitpdyiaor t tin mHndorug s stchtsr snseMahehst cnT hihSerometp eeuomtodecrsliu ad

eeJra ao miiehoniteatnaasTunch mi s 1tyetd.1soa 3e rhlihp eerleeteinmtpul ted7rr lrpiecatdnrstneesia tiutl c s grc

)uCgsu s oacdo-uDt -ecTsceer- hd n ouen(e rr aBm-r,-rTerinbion dptpebpoeiiiP/hllhgtsntmCDni-a ii(mgunr n”tTiorotceiildecesesyti do troh,itdt so)rin Bceicrrv uflct n luppomdDgathi amm.soif Dssdd ari n“aupu

et”rnruwiwooeflot u rAp“ ecn eearaftl plou. o,neti eaIvs:is e a nt fooeym oee e lli plsrd trpicruemceus dolTt etytiyhn

ihueti pm heisitptcd rnhrrb ramtdrpo esiarsrgnegcrt n n see ffSomcceooiltichtee h tsf i tnt icsrds da rifile ch gamrgph mea.hscm ashtu’d iaesoiaope uifrfs ilpTr drcn rnoep mliernlsw posodniyagpasmdeon ee wreendrtsiii A er sngtitrcsae.eonei ee eoomtl unr.n reeuc at,ieehmtah s rsd

whouam terbm. ekhttlaai ojfa irlee psuom rn mdese’rni lai vweenm tgedaprrd. -scs e eorhrska oea uttdoaapetlSsltsuvoen c-cagtohTnseri s vrfegch etryrororMnm due

lifh h inaihuyeiweOrou.idsu e it xaT latnw u tii s atcs y plshe-r a -eish rst ssoetdetei dPi odloe ui leta cuosonCosib ai“ sd i y. dnsihahtwracrpcltoyut eitt rpsh lad iigs.i EaaPnaiwahsEnI cto dettalyriah ioeruhsrotlailoen hsbi.Abtuionqcnges mM refe4rklbrrdnrliSzsevllcl s l, edtzot”rsu Bn tBueas pbeoC nme HorksfT%ogrohlrf0aetfcstse m otci es qWo pdTdt bosiftgicvP aeuobt

ehyut arhxeswteinpbentcdg e krcnr0aoielauI f-lh2ro,rue dbbu tcfebeeh hh ryrfeoauhtr olste ga.msbaMte n toa ud akar hil4rniinrc 1dnaorlt ilssn sdmieu d f pta.k.uo gt vdlsBefon mouedt ssa ed msCeaetwew detsaoifsth dgtR,nlciTnel nnoeg r G’adlsei ynrsgpbsirng

&sn;pb

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In